Top Markets
#1 Black Phoenix Black Phoenix +355.09%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.07%
#4 Akedo Akedo +59.66%
#5 OpenEden OpenEden +47.92%
#6 Acurast Acurast +32.03%
#7 BasedHype BasedHype +27.23%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +20.78%
#10 Humanity Humanity +16.94%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
주식 순위 #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
주가
$0.13607016
마지막 동기화: 2024-09-10
시가총액
$112.29K
변동 (1일)
22.46%
변동 (1년)
0.00%
국가
GB
거래 BiVictriX Therapeutics Plc (BVX)

카테고리

Healthcare
BiVictriX Therapeutics Plc (BVX)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
BiVictriX Therapeutics Plc의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
BiVictriX Therapeutics Plc의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE